Compare AFG & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AFG | RDY |
|---|---|---|
| Founded | 1872 | 1984 |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.6B |
| IPO Year | N/A | N/A |
| Metric | AFG | RDY |
|---|---|---|
| Price | $136.67 | $13.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $131.00 | $16.90 |
| AVG Volume (30 Days) | 382.4K | ★ 1.1M |
| Earning Date | 02-03-2026 | 01-22-2026 |
| Dividend Yield | ★ 2.58% | 0.51% |
| EPS Growth | N/A | ★ 9.95 |
| EPS | ★ 9.52 | 0.79 |
| Revenue | ★ $8,011,000,000.00 | $3,851,623,984.00 |
| Revenue This Year | N/A | $6.12 |
| Revenue Next Year | $4.98 | $2.58 |
| P/E Ratio | ★ $14.35 | $17.60 |
| Revenue Growth | 1.20 | ★ 14.10 |
| 52 Week Low | $114.73 | $12.26 |
| 52 Week High | $150.02 | $16.17 |
| Indicator | AFG | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 45.44 | 44.34 |
| Support Level | $137.09 | $14.03 |
| Resistance Level | $139.75 | $14.16 |
| Average True Range (ATR) | 1.83 | 0.13 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 20.88 | 1.14 |
American Financial Group Inc is a holding company that is engaged in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. The Company operates through two segments: Property & Casualty Insurance and Other. The Property & Casualty segment includes Property & Transportation, covering buses, trucks, marine, agriculture, and commercial property; Specialty Casualty, offering excess & surplus, liability, and professional insurance; and Specialty Financial, providing risk management for lending and leasing institutions, fidelity and surety products, and trade credit insurance. The company's insurance operations are conducted through the Great American Insurance Group.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.